ARMP vs REGN: Which Stock is Better?
Side-by-side comparison of Armata Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026
ARMP
Armata Pharmaceuticals Inc
$10.60
REGN
Regeneron Pharmaceuticals Inc
$759.86
Key Metrics Comparison
| Metric | ARMP | REGN | Winner |
|---|---|---|---|
| Market Cap | $385.91M | $80.33B | REGN |
| P/E Ratio | N/A | 18.45 | REGN |
| EPS (TTM) | $N/A | $41.18 | REGN |
| Revenue Growth | -0.6% | 0.0% | REGN |
| Gross Margin | -416.4% | 44.6% | REGN |
Analyze ARMP
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARMP or REGN a better investment?
Comparing ARMP and REGN: Armata Pharmaceuticals Inc has a market cap of $385.91M while Regeneron Pharmaceuticals Inc has $80.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARMP and REGN?
ARMP (Armata Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARMP or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARMP or REGN?
REGN has higher revenue growth at 0.0% vs -0.6% for ARMP.
Which company is more profitable: ARMP or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -416.4% for ARMP.
Which is the larger company: ARMP or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $80.33B compared to $385.91M for ARMP.
Should I buy ARMP or REGN in 2026?
Both ARMP and REGN have investment merit. ARMP trades at $10.60 while REGN trades at $759.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARMP and REGN stock?
Key differences: Market Cap ($385.91M vs $80.33B), P/E Ratio (N/A vs 18.5x), Revenue Growth (-0.6% vs 0.0%), Gross Margin (-416.4% vs 44.6%).